Ask people what causes liver cancer, and most will name two things: heavy drinking and hepatitis. Both are true. But there is a third cause that rarely makes the list, and it is one the United States government put there in writing: cigarette smoking. The liver's job is to cleanse the blood of toxins, and every carcinogen a smoker inhales eventually passes through it. For decades the warning label said nothing about the liver, and the advertising never hinted at it — but since 2014 the science has been settled at the highest level. Smoking is a cause of liver cancer.
This piece continues the firm's series on the smoking-caused cancers the public rarely hears about — alongside our guides to kidney cancer, bladder cancer, esophageal cancer, laryngeal and throat cancer, and pancreatic cancer. Liver cancer belongs on that list. Below: what liver cancer is, why it sits on the Surgeon General's smoking list, the detox-organ biology that explains it, how large the risk really is, a distinctive fact these cases turn on — that smoking does not just cause liver cancer but is tied to worse outcomes once it strikes — the “it could have been anything” defense the tobacco companies raise (which matters more here than in almost any other smoking cancer), and how a smoking-related liver cancer claim fits the same liability framework the firm uses in its lung cancer, COPD, and bladder cancer matters.
What Liver Cancer Is
The liver is the body's largest internal organ and its chemical-processing plant — it filters the blood, breaks down drugs and toxins, and manufactures the proteins that keep blood clotting and metabolism running. The most common primary liver cancer by far is hepatocellular carcinoma (HCC), which begins in the main functioning liver cells, the hepatocytes. A less common type, intrahepatic cholangiocarcinoma, arises in the bile ducts inside the liver. Most liver cancer develops on a background of long-term liver injury — chronic inflammation and, often, cirrhosis — that has been quietly scarring the organ for years before a tumor forms.
Liver cancer is often found late. The liver has a large functional reserve and few nerve endings deep inside it, so a tumor can grow for a long time without obvious symptoms. When symptoms appear, they tend to be pain or a mass in the upper right abdomen, unexplained weight loss, jaundice (a yellowing of the skin and eyes), or a worsening of an underlying liver condition. Caught early and confined to the liver, the disease can sometimes be treated with surgery, ablation, or transplant; caught late, after it has spread or the liver is failing, it becomes one of the more dangerous cancers a person can face. That gap between an early and a late diagnosis is where the smoking connection matters twice over — once for whether the cancer happens at all, and again, as explained below, for how it behaves once it does.
Why Liver Cancer Is on the Surgeon General's Smoking List
The link between smoking and liver cancer is not a plaintiff's theory. It is the conclusion of the United States government's highest scientific authority on tobacco. The landmark 2014 Surgeon General's report, The Health Consequences of Smoking—50 Years of Progress, formally added liver cancer to the list of diseases for which the evidence is sufficient to infer a causal relationship with cigarette smoking — one of the new cancers that half-century review confirmed. The International Agency for Research on Cancer reached the same finding, classifying the evidence for a causal association between tobacco smoking and liver cancer as sufficient, and the American Cancer Society lists smoking among the risk factors for the disease.
The biology explains why. Cigarette smoke is not a single chemical but a mixture of dozens of established carcinogens — including tobacco-specific nitrosamines, polycyclic aromatic hydrocarbons, and aromatic amines. Those compounds are absorbed through the lungs into the bloodstream, and here is the key: the liver is the organ that detoxifies the blood. Every carcinogen circulating in a smoker's blood is delivered to the liver to be metabolized, and in the process some of those chemicals are converted into even more reactive forms that bind to and damage the DNA of liver cells. Smoking also promotes the chronic inflammation, oxidative stress, and fibrosis that scar the liver over time — the same cirrhotic soil on which most liver cancer grows. An organ does not have to touch smoke to be harmed by it; the liver is harmed precisely because it is the body's first line of defense against everything the smoke carries into the blood.
How Big Is the Smoking Risk?
Meaningfully elevated, and larger the more a person smoked. The 2014 Surgeon General's report found roughly a 51 to 70 percent higher risk of liver cancer among current smokers. The most comprehensive modern measurement comes from the Liver Cancer Pooling Project, a consortium that combined 14 U.S. prospective cohort studies covering more than 1.5 million people. Its findings:
- Current smokers had about 1.86 times the risk of hepatocellular carcinoma of people who never smoked — nearly double.
- Former smokers had about 1.24 times the risk — still elevated, but clearly lower than current smokers, the pattern that shows quitting helps.
- Among people who had quit more than 30 years earlier, the risk fell back to nearly that of never smokers — strong confirmation that the smoking, not some fixed trait of smokers, was driving the excess risk.
- The American Cancer Society states plainly that people who smoked and then stopped have a lower risk than those who still smoke, but that both groups have a higher risk than people who never smoked — the dose-and-recency gradient epidemiologists rely on to separate genuine causation from coincidence.
Those figures put liver cancer squarely among the diseases cigarettes are known to cause. A person does not have to develop lung cancer for smoking to have taken a serious toll — and quitting, even long ago, measurably changed the odds.
A Distinctive Fact: Smoking Doesn't Just Cause Liver Cancer — It Worsens It
Liver cancer cases carry an added dimension that many other smoking-disease cases do not. The research does not stop at whether smoking causes the tumor; it also links smoking to how badly that tumor behaves. Studies of patients who had liver tumors surgically removed have found that a history of smoking is associated with a higher rate of late recurrence of hepatocellular carcinoma after resection, and research in hepatitis B patients has tied smoking to worse outcomes after liver-cancer surgery. A broad systematic review of the epidemiological literature likewise identified cigarette smoking as a risk factor not only for developing hepatocellular carcinoma but for dying from it.
That matters legally as well as medically. In a tobacco-disease case the harm at issue is not only that the client developed cancer, but the full course and severity of that cancer — and the evidence suggesting smoking pushes liver cancer toward recurrence and worse survival speaks directly to the extent of the injury the product caused. It is another reason the paper trail in these cases has to be read by someone who understands both the medicine and the law.
The “It Could Have Been Anything” Defense — and Why Synergy Cuts the Other Way
Liver cancer has more than one major risk factor, and tobacco defendants know it — here more than in almost any other smoking cancer. Expect the familiar move: point to something other than the cigarettes. He had hepatitis C. She drank. There was cirrhosis. There was fatty liver disease. The argument trades on the fact that chronic hepatitis B and C infection, heavy alcohol use, cirrhosis from any cause, and non-alcoholic fatty liver disease are all genuine, powerful drivers of liver cancer. It does not end the case — and the science often turns it around.
The reason is that smoking does not merely sit alongside those factors; the research shows it can act synergistically with them. Case-control studies in American men and women have reported synergy between cigarette smoking and hepatitis C in men, and between smoking and heavy alcohol use in women, in the development of hepatocellular carcinoma — meaning the combined effect exceeds what either factor would produce alone. Far from letting the cigarettes off the hook, that finding places smoking in the middle of the causal picture: it can be the factor that tipped a scarred but not-yet-cancerous liver into malignancy. In product-liability law, a manufacturer whose product was a substantial contributing factor to an injury does not escape responsibility merely by naming another factor that also played a part — and where the evidence shows smoking amplified the very risks the defense points to, the presence of hepatitis or alcohol becomes part of the plaintiff's story rather than an answer to it.
This is the kind of record where the firm's Medical-Legal Expert earns his place. Herb Borroto, M.D., J.D., who holds both a medical degree and a law degree, reads the imaging, the surgical pathology, the hepatitis serologies, the alcohol and liver-function history, and the smoking record together — separating the parts of the causal story that support a claim from the parts a defense expert will attack, in a way a purely legal review has no reason to frame and a purely clinical review has no reason to connect to liability.
The Legal Framework
Smoking-related liver cancer cases proceed on the same liability theories as other smoking-disease cases against the tobacco industry:
- Negligent design, manufacture, and marketing of cigarettes.
- Strict product liability for an unreasonably dangerous product.
- Failure to warn about the full range of cancers smoking causes — including cancers, like liver cancer, of organs that never touch the smoke directly.
- Fraud and misrepresentation about the safety and addictiveness of the products.
- Civil conspiracy among manufacturers to suppress and distort health research.
The internal industry records unearthed in prior tobacco litigation — the documents showing what the companies knew about the harms of their product and when — remain central evidence. Our companion piece on how tobacco companies hid the truth walks through that record. Alex Alvarez, the firm's Managing Partner and a Board Certified Civil Trial Lawyer, brings that documentary history together with each client's own smoking and medical records to build the causation case a liver cancer claim requires — including the answer to the “it could have been anything” defense described above. The carcinogen science here overlaps closely with the firm's lung cancer cases and its other smoking-caused cancer matters.
What a Liver Cancer Case Needs
- Documentation of the diagnosis — the imaging (CT, MRI, or ultrasound), any biopsy or surgical pathology confirming hepatocellular carcinoma or intrahepatic cholangiocarcinoma, and the staging.
- A substantial smoking history, measured in pack-years.
- Brand identification — which cigarettes were smoked, and for how long.
- The medical history that bears on the other recognized risk factors — hepatitis B and C status, alcohol history, cirrhosis, and fatty liver disease — so those factors can be accounted for and, where the science supports it, shown to have acted together with the smoking rather than instead of it.
- Causation testimony from an appropriate expert familiar with the smoking–liver cancer literature.
- Documentation of the disease's impact — the surgery or transplant, any recurrence and further treatment, the decline, and, in cases brought after a death, the cause-of-death records and disease-course documentation.
The unglamorous paperwork behind these elements is what carries a case. Our guide to smoking history documentation covers the records that build or break a tobacco claim, and our wrongful death family guide walks through what a family should know when liver cancer has taken a loved one.
The Jurisdictions We Serve
The Alvarez Law Firm represents smokers and families in Hawaii, Illinois, Nevada, Oregon, Pennsylvania, and the U.S. Virgin Islands. Each of those jurisdictions has its own filing deadlines, its own substantive law on tobacco product liability, and its own version of the discovery rule — how long after a diagnosis, or a death, a claim must be filed. Because those deadlines are unforgiving and easy to overlook while a family is absorbed in treatment, talk to counsel licensed in the relevant state about how they apply to your situation. Waiting can foreclose options that were available earlier.
Frequently Asked Questions
Does smoking cause liver cancer?
Yes. The 2014 Surgeon General's report, The Health Consequences of Smoking—50 Years of Progress, added liver cancer to the list of diseases for which the evidence is sufficient to infer a causal relationship with cigarette smoking. The International Agency for Research on Cancer reached the same conclusion, and the American Cancer Society lists smoking among the risk factors for liver cancer. Carcinogens in cigarette smoke are absorbed into the blood and processed by the liver, the organ that detoxifies the bloodstream, where they and their metabolites damage liver-cell DNA and promote the chronic inflammation and cirrhosis on which liver cancer develops.
How much does smoking raise the risk of liver cancer?
Meaningfully. The 2014 Surgeon General's report found roughly a 51 to 70 percent higher risk of liver cancer in current smokers. The Liver Cancer Pooling Project, which combined 14 U.S. cohort studies covering more than 1.5 million people, reported that current smokers had about 1.86 times the risk of hepatocellular carcinoma of never smokers, and former smokers about 1.24 times the risk. Among people who had quit more than 30 years earlier, the risk fell back to nearly that of never smokers, confirming both the causal link and the benefit of quitting.
Can you file a lawsuit for smoking-related liver cancer?
Potentially. A smoking-caused liver cancer proceeds on the same product-liability theories as other tobacco-disease claims, including negligent design and marketing, strict product liability, failure to warn, fraud, and civil conspiracy. Because hepatitis and alcohol are also major liver-cancer risk factors, causation must be developed carefully — but research showing that smoking acts synergistically with those factors, rather than in place of them, often strengthens the smoking claim. Every jurisdiction has its own filing deadline, so a longtime smoker diagnosed with liver cancer, or a family that lost someone to it, should speak with counsel licensed in the relevant state promptly.
If You or a Family Member Has Been Diagnosed
If you have a substantial smoking history and have been diagnosed with liver cancer — or your family lost a loved one to it — a free, confidential case review is the right next step. The same conversation that produces a viable lung cancer case can produce a viable liver cancer case.
- Read about the firm's other smoking-caused cancer cases: Kidney Cancer, Bladder Cancer, Pancreatic Cancer, and Esophageal Cancer.
- Read the wrongful death family guide: Smokers Wrongful Death Family Guide.
- Learn how the industry concealed the harms: How Tobacco Companies Hid the Truth.
Free case review. No fees unless we recover compensation for you.
Sources
- U.S. Surgeon General — "The Health Consequences of Smoking—50 Years of Progress" (2014), which added liver cancer to the diseases causally linked to smoking and reported roughly a 51–70% higher risk in current smokers. cdc.gov/tobacco/sgr
- Petrick JL, et al. "Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project." British Journal of Cancer, 2018 — 14 U.S. cohorts; current-smoker HCC hazard ratio 1.86, former-smoker 1.24, and near-baseline risk after quitting >30 years. nature.com
- American Cancer Society — "Liver Cancer Risk Factors," listing smoking as a risk factor and noting former smokers have lower risk than current smokers but higher than never smokers. cancer.org
- Abdel-Rahman O, et al. "Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: An updated systematic review of 81 epidemiological studies." 2017 — smoking a risk factor for both developing and dying from HCC. pubmed.ncbi.nlm.nih.gov
- Hassan MM, et al. "Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women." Cancer — documented synergy between smoking and HCV in men and smoking and heavy alcohol use in women. pmc.ncbi.nlm.nih.gov
- International Agency for Research on Cancer (IARC), WHO — Monographs concluding sufficient evidence for a causal association between tobacco smoking and liver cancer. monographs.iarc.who.int